CCL17 and Alzheimer disease: On the other hand, both TLR2 ligands had no significant effect on the mRNA expression of CCL1, CCL17, and CCL27 in PBMCs from AD patients compared with healthy controls (Figures 2(a), 2(e), and 2(h)).